Effects of pinacidil on the heart: Serial electrocardiographic and echocardiographic observations

C. Shub, P. K. Zachariah, D. M. Ilstrup, A. J. Tajik

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In a prospective, double-blind study comparing pinacidil to hydralazine in mild systemic hypertension, 33 patients were followed with serial echocardiograms and electrocardiograms. There were four study groups: pinacidil and hydralazine (long-term therapy), and pinacidil and placebo (short-term therapy). There were no significant changes in mean echo LV mass or in LV systolic function in any of the groups. One patient in each group developed LVH de novo despite decreases in blood pressure. Four patients receiving pinacidil therapy (23%) developed new T-wave abnormalities and in 1, the initially abnormal T waves returned to normal at follow-up. Seven of 9 T-wave abnormalities were minor (Minnesota Code) and were not associated with any echocardiographic abnormality. One patient in the placebo group also developed new minor T-wave abnormalities. One patient receiving pinacidil therapy who had new major T-wave abnormalities developed cardiac ischemia. There were no other cardiac events.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalCanadian Journal of Cardiology
Volume3
Issue number5
StatePublished - 1987

Fingerprint

Pinacidil
Hydralazine
Placebos
Therapeutics
Double-Blind Method
Electrocardiography
Ischemia
Blood Pressure
Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Shub, C., Zachariah, P. K., Ilstrup, D. M., & Tajik, A. J. (1987). Effects of pinacidil on the heart: Serial electrocardiographic and echocardiographic observations. Canadian Journal of Cardiology, 3(5), 223-229.

Effects of pinacidil on the heart : Serial electrocardiographic and echocardiographic observations. / Shub, C.; Zachariah, P. K.; Ilstrup, D. M.; Tajik, A. J.

In: Canadian Journal of Cardiology, Vol. 3, No. 5, 1987, p. 223-229.

Research output: Contribution to journalArticle

Shub, C, Zachariah, PK, Ilstrup, DM & Tajik, AJ 1987, 'Effects of pinacidil on the heart: Serial electrocardiographic and echocardiographic observations', Canadian Journal of Cardiology, vol. 3, no. 5, pp. 223-229.
Shub, C. ; Zachariah, P. K. ; Ilstrup, D. M. ; Tajik, A. J. / Effects of pinacidil on the heart : Serial electrocardiographic and echocardiographic observations. In: Canadian Journal of Cardiology. 1987 ; Vol. 3, No. 5. pp. 223-229.
@article{b24b8a208f2341cb82ba597eb382e05c,
title = "Effects of pinacidil on the heart: Serial electrocardiographic and echocardiographic observations",
abstract = "In a prospective, double-blind study comparing pinacidil to hydralazine in mild systemic hypertension, 33 patients were followed with serial echocardiograms and electrocardiograms. There were four study groups: pinacidil and hydralazine (long-term therapy), and pinacidil and placebo (short-term therapy). There were no significant changes in mean echo LV mass or in LV systolic function in any of the groups. One patient in each group developed LVH de novo despite decreases in blood pressure. Four patients receiving pinacidil therapy (23{\%}) developed new T-wave abnormalities and in 1, the initially abnormal T waves returned to normal at follow-up. Seven of 9 T-wave abnormalities were minor (Minnesota Code) and were not associated with any echocardiographic abnormality. One patient in the placebo group also developed new minor T-wave abnormalities. One patient receiving pinacidil therapy who had new major T-wave abnormalities developed cardiac ischemia. There were no other cardiac events.",
author = "C. Shub and Zachariah, {P. K.} and Ilstrup, {D. M.} and Tajik, {A. J.}",
year = "1987",
language = "English (US)",
volume = "3",
pages = "223--229",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of pinacidil on the heart

T2 - Serial electrocardiographic and echocardiographic observations

AU - Shub, C.

AU - Zachariah, P. K.

AU - Ilstrup, D. M.

AU - Tajik, A. J.

PY - 1987

Y1 - 1987

N2 - In a prospective, double-blind study comparing pinacidil to hydralazine in mild systemic hypertension, 33 patients were followed with serial echocardiograms and electrocardiograms. There were four study groups: pinacidil and hydralazine (long-term therapy), and pinacidil and placebo (short-term therapy). There were no significant changes in mean echo LV mass or in LV systolic function in any of the groups. One patient in each group developed LVH de novo despite decreases in blood pressure. Four patients receiving pinacidil therapy (23%) developed new T-wave abnormalities and in 1, the initially abnormal T waves returned to normal at follow-up. Seven of 9 T-wave abnormalities were minor (Minnesota Code) and were not associated with any echocardiographic abnormality. One patient in the placebo group also developed new minor T-wave abnormalities. One patient receiving pinacidil therapy who had new major T-wave abnormalities developed cardiac ischemia. There were no other cardiac events.

AB - In a prospective, double-blind study comparing pinacidil to hydralazine in mild systemic hypertension, 33 patients were followed with serial echocardiograms and electrocardiograms. There were four study groups: pinacidil and hydralazine (long-term therapy), and pinacidil and placebo (short-term therapy). There were no significant changes in mean echo LV mass or in LV systolic function in any of the groups. One patient in each group developed LVH de novo despite decreases in blood pressure. Four patients receiving pinacidil therapy (23%) developed new T-wave abnormalities and in 1, the initially abnormal T waves returned to normal at follow-up. Seven of 9 T-wave abnormalities were minor (Minnesota Code) and were not associated with any echocardiographic abnormality. One patient in the placebo group also developed new minor T-wave abnormalities. One patient receiving pinacidil therapy who had new major T-wave abnormalities developed cardiac ischemia. There were no other cardiac events.

UR - http://www.scopus.com/inward/record.url?scp=0023186576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023186576&partnerID=8YFLogxK

M3 - Article

C2 - 3300903

AN - SCOPUS:0023186576

VL - 3

SP - 223

EP - 229

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 5

ER -